Financials
Publication of Annual Report | Apr. 25, 2025 |
Half-year Report | Aug. 13, 2024 |
Publication of Annual Report | Apr. 29, 2024 |
Half-year Report | Aug. 17, 2023 |
Final Results | Apr. 26, 2023 |
Half-year Report | Aug. 16, 2022 |
Imaging Biometrics Announces Channel Partnership | Jul. 11, 2022 |
Proxies
Result of AGM | May. 22, 2025 |
Notice of AGM | Apr. 29, 2025 |
Result of AGM | May. 29, 2024 |
Result of AGM | May. 23, 2023 |
AGM Statement | May. 23, 2023 |
Result of AGM | May. 30, 2022 |
Notice of AGM | May. 05, 2022 |
Ownership Update
Holding(s) in Company | Oct. 15, 2024 |
Holding(s) in Company | Oct. 14, 2024 |
PDMR dealing and TR1 announcement | Oct. 14, 2024 |
Grant of Options | Mar. 05, 2024 |
Holding(s) in Company | Mar. 01, 2024 |
Holding(s) in Company | Mar. 01, 2024 |
Holding(s) in Company | Jan. 22, 2024 |
Announcements
Application: FDA Breakthrough Therapy Designation | May. 02, 2025 |
Promising Preliminary Results of Phase 1 Study | Apr. 11, 2025 |
Placing to raise £250,000 | Mar. 18, 2025 |
IB Expands Distribution with Blackford | Feb. 03, 2025 |
Operations Update | Jan. 22, 2025 |
IB and Prism Secure First Installation | Jan. 10, 2025 |
Imaging Biometrics Expands Distribution | Nov. 20, 2024 |